Henan Lingrui Pharmaceutical Co., Ltd.

Informe acción SHSE:600285

Capitalización de mercado: CN¥14.0b

Henan Lingrui Pharmaceutical Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Wei Xiong

Chief Executive Officer (CEO)

CN¥1.8m

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEO0.6%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Stock Catapults 27% Though Its Price And Business Still Lag The Market

May 07
Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Henan Lingrui Pharmaceutical's (SHSE:600285) Earnings May Just Be The Starting Point

May 02
Henan Lingrui Pharmaceutical's (SHSE:600285) Earnings May Just Be The Starting Point

Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Held Back By Insufficient Growth Even After Shares Climb 27%

Mar 04
Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) Held Back By Insufficient Growth Even After Shares Climb 27%

Should You Be Adding Henan Lingrui Pharmaceutical (SHSE:600285) To Your Watchlist Today?

Feb 29
Should You Be Adding Henan Lingrui Pharmaceutical (SHSE:600285) To Your Watchlist Today?

CEO

Wei Xiong (37 yo)

no data

Permanencia

CN¥1,772,800

Compensación

Mr. Wei Xiong serves as General Manager and Director at Henan Lingrui Pharmaceutical Co. Ltd. and served as its Chairman and Managing Director.